Clinical and electrophysiological characteristics of respiratory onset amyotrophic lateral sclerosis: a single-centre study. 2023

Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
Department of Rehabilitation Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.

BACKGROUND We compared the clinical characteristics of patients with respiratory, bulbar and limb onset amyotrophic lateral sclerosis (ALS) who visited a single tertiary centre for 8 years. METHODS Total of 115 ALS patients with respiratory, bulbar and limb onset ALS, including sex, body mass index (BMI), presence of lung disease, age at diagnosis, disease duration after initial symptoms, ALS Functional Rating Scale (ALSFRS-R) and progression rate (Delta-FS), pulmonary function, amplitude and distal latency (DL) of the phrenic nerves and blood creatine kinase (CK) and uric acid levels were collected. RESULTS The prevalence of respiratory, bulbar and limb onset ALS were 5.2%, 28.7% and 66.1%, respectively. The mean age at diagnosis and ALSFRS-R were 67.8 ± 5.5, 63.8 ± 10.1 and 59.2 ± 11.7 in the descending order. The mean amplitude (0.18 ± 0.10 mV) and DL (9.5 ± 1.7 ms) of the phrenic nerves were significantly decreased and prolonged in respiratory onset ALS compared with other types of ALS patients. Patients with respiratory onset ALS had normal creatine kinase (CK) levels, whereas patients with other types of ALS had increased CK levels. CONCLUSIONS Although rare, respiratory onset ALS may occur and should be considered during the initial differential diagnosis. In this study, patients with respiratory onset ALS were characterised by male predominance, with a higher baseline ALSFRS-R, lower BMI and phrenic nerve study well discriminated respiratory onset ALS from bulbar or limb onset ALS patients.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000690 Amyotrophic Lateral Sclerosis A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94) ALS - Amyotrophic Lateral Sclerosis,Lou Gehrig Disease,Motor Neuron Disease, Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis With Dementia,Amyotrophic Lateral Sclerosis, Guam Form,Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam,Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1,Charcot Disease,Dementia With Amyotrophic Lateral Sclerosis,Gehrig's Disease,Guam Disease,Guam Form of Amyotrophic Lateral Sclerosis,Lou Gehrig's Disease,Lou-Gehrigs Disease,ALS Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1,Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam,Disease, Guam,Disease, Lou-Gehrigs,Gehrig Disease,Gehrigs Disease,Sclerosis, Amyotrophic Lateral
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
January 1986, Rinsho shinkeigaku = Clinical neurology,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
February 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
June 2007, Journal of neurology, neurosurgery, and psychiatry,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
December 2007, Europa medicophysica,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
June 2006, Revue neurologique,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
February 2019, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
May 2018, Acta odontologica Scandinavica,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
January 1973, Revista espanola de oto-neuro-oftalmologia y neurocirugia,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
January 2021, Neuro-degenerative diseases,
Min Cheol Chang, and Sang Gyu Kwak, and Jin-Mo Park, and Donghwi Park, and Jin-Sung Park
October 2013, American journal of epidemiology,
Copied contents to your clipboard!